CRMD FY 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$205,562

Operating Income

-$49M

Net Income

-$46M

EPS (Diluted)

$-0.91

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$39M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$82M

Total Liabilities

$12M

Stockholders' Equity

$70M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$65,408	-100.0%
Gross Profit	-$205,562	$61,674	-433.3%
Operating Income	-$49M	-$31M	-59.9%
Net Income	-$46M	-$30M	-56.0%